The c-Jun NH2-terminal
kinase (JNK) pathway represents one subgroup of MAP
kinases that are activated primarily by
cytokines and exposure to environmental stress. Autophagy is a protein-degradation system characterized by the formation of double-membrane vacuoles termed autophagosomes. Autophagy-related gene
beclin 1 plays a key role in autophagosome formation. However, the relationships between activation of JNK pathway, autophagy induction and
Beclin 1 expression remain elusive. In this study, we used human
cancer cell lines CNE2 and Hep3B to investigate the role of JNK-mediated
Beclin 1 expression in
ceramide-induced autophagic cell death.
Ceramide-treated cells exhibited the characteristics of autophagy (that is, acidic vesicular organelle formation and the LC3-II generation). JNK was activated in these two cell lines exposed to
ceramide and the phosphorylation of c-Jun also increased. In the meantime, we found that
ceramide upregulated
Beclin 1 expression in
cancer cells. The upregulation of
Beclin 1 expression could be blocked by
SP600125 (a specific inhibitor of JNK) or a
small interfering RNA (
siRNA) directed against JNK1/2 or c-Jun.
Chromatin immunoprecipitation and
luciferase reporter analysis revealed that c-Jun was involved in the regulation of
beclin 1 transcription in response to
ceramide treatment. In addition, inhibition of JNK activity by
SP600125 could inhibit autophagy induction by
ceramide. Furthermore,
Beclin 1 knockdown by
siRNA also inhibited
ceramide-mediated autophagic cell death. JNK-mediated
Beclin 1 expression was also observed in
topotecan-induced autophagy. These data suggest that activation of JNK pathway can mediate
Beclin 1 expression, which plays a key role in autophagic cell death in
cancer cells.